Method for synthesizing 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives

A method for synthesizing 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives under mild conditions addresses the challenges of high cost and complexity in existing methods, enabling efficient and cost-effective commercial production.

JP7577731B2Active Publication Date: 2024-11-05GLACEUM INC
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
JP2022506236
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-07-30
Filing Date
2020-07-20
Publication Date
2024-11-05
Estimated Expiration
2040-07-20

AI Technical Summary

Technical Problem

Existing methods for synthesizing 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives are difficult and expensive, requiring low temperatures and specific reducing agents, making mass production challenging.

Method used

A method involving the reduction of a compound of Formula 1 to Formula 2, followed by coupling with Formula 3 under mild conditions, without the need for extreme temperatures or expensive reducing agents, and subsequent cyclization to produce Formula 4 and further processing to obtain derivatives.

Benefits of technology

Enables simple and economically viable production of 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives, facilitating commercial-scale synthesis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007577731000001
    Figure 0007577731000001
  • Figure 0007577731000002
    Figure 0007577731000002
  • Figure 0007577731000003
    Figure 0007577731000003
Patent Text Reader

Abstract

The present invention relates to a method for synthesizing 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives, and by using the method, 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives can be effectively synthesized.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] This specification claims the benefit of the filing date of Korean Patent Application No. 10-2019-0092711, filed with the Korean Intellectual Property Office on July 30, 2019, the entire contents of which are incorporated herein by reference. The present invention relates to a method for synthesizing 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives. [Background technology]

[0002] Patent Document 1 [Korea Patent Publication No. 10-2015-0075030] discloses that pyranochromenylphenol derivatives are effective in preventing and treating various metabolic syndromes including hyperlipidemia, fatty liver, glucose metabolism disorder, diabetes, and obesity, and Patent Document 2 [Korea Patent Publication No. 10-2018-0037584] discloses a method for preparing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivatives as key intermediates for synthesizing these pyranochromenylphenol derivatives. That is, Patent Document 2 discloses a method for synthesizing various derivatives disclosed in Patent Document 1 by coupling a compound of formula A-1 with a compound of formula A-2 to obtain a compound of formula A-3, reducing the compound of formula A-4, carrying out a cyclization reaction to obtain a compound of formula A-5, and finally carrying out a hydrogenation reaction to synthesize various derivatives disclosed in Patent Document 1. Here, the step of preparing the compound of formula A-4 from the compound of formula A-3 is carried out by L-selectride R The reaction was carried out by slowly adding L-selectride at a cryogenic temperature of -78°C. R is expensive, so that it is very laborious and difficult to mass-produce the 2-((6-(hydroxymethyl)-2H-chromen-5-yl)oxy)-1-phenylethanone derivative represented by the chemical formula A-4 on a commercial scale.

[0003] [ka]

[0004] Therefore, there is a need for a synthetic method capable of mass-producing the 2-((6-(hydroxymethyl)-2H-chromen-5-yl)oxy)-1-phenylethanone derivative represented by the chemical formula A-4 under mild conditions. [Prior art documents] [Patent documents]

[0005] [Patent Document 1] Republic of Korea Patent Publication No. 10-2015-0075030 [Patent Document 2] Republic of Korea Patent Publication No. 10-2018-0037584 Summary of the Invention [Problem to be solved by the invention]

[0006] The technical problem to be solved by the present invention is to provide a synthetic method capable of mass-producing 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives under mild conditions. However, the problems to be solved by the present invention are not limited to the above problems, and other problems not mentioned will be clearly understood by those skilled in the art from the following description. [Means for solving the problem]

[0007] One embodiment of the present invention provides a method for synthesizing a 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivative represented by formula 4, comprising the steps of: (a) reducing a compound represented by formula 1 to produce a compound represented by formula 2; and (b) coupling the compound represented by formula 2 with a compound represented by formula 3: [ka] In the above chemical formula: The dotted lines are optional double bonds; R1 and R2 are each independently one of a hydrogen atom; a substituted or unsubstituted, linear or branched C1-C6 alkyl group; a halogen atom; a substituted or unsubstituted, linear or branched C1-C6 alkoxy group; a substituted or unsubstituted, linear or branched C1-C4 thioalkyl group; a substituted or unsubstituted allyloxy group; a substituted or unsubstituted aryloxy group; and a phenyl group; R3 is any one of a hydrogen atom; a C1-C3 alkyl group; a C1-C3 alkoxy group; and a halogen atom; R4 and R5 are each independently one of a hydrogen atom and a C1-C2 alkyl group; P is one of a substituted or unsubstituted, straight or branched C1-C4 alkyl group; a substituted or unsubstituted benzyl group; an allyl group; a t-butyldimethylsilyl group; a t-butyldiphenylsilyl group; a dimethylphenylsilyl group; a trimethylsilyl group; MeSO2; a p-toluenesulfonyl group; and a 2,4,6-trimethylbenzenesulfonyl group; n is 1 to 3; When there are multiple OPs, they may be the same or different; In the case of the substituted alkyl group, substituted alkoxy group, substituted thioalkyl group, substituted allyloxy group, substituted aryloxy group and substituted benzyl group, the substituent is any one of a benzyloxy group, a halogen atom, a linear or branched C1-C5 alkyl group, a linear or branched C1-C5 alkoxy group, a linear or branched C1-C3 thioalkyl group, a nitro group and a naphthalene group.

[0008] Another embodiment of the present invention provides a method for synthesizing a 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative of formula I, comprising the steps of (i) cyclizing a compound of formula 4 prepared according to an embodiment of the present invention to produce a compound of formula 5, and (ii) reducing the compound of formula 5: [ka] In the above chemical formula, the dotted line is an optional double bond, and R1 to R5, P and n are the same as defined in the above chemical formulas 1 to 4.

[0009] Yet another embodiment of the present invention provides a 6-(hydroxymethyl)chromen-5-ol derivative or a solvate thereof represented by the following chemical formula 2: [ka] In the above Chemical Formula 2, R3 is any one of a hydrogen atom; a C1-C3 alkyl group; a C1-C3 alkoxy group; and a halogen atom; R4 and R5 are each independently one of a hydrogen atom; and a C1-C2 alkyl group. Effect of the Invention

[0010] The process according to one embodiment of the present invention allows for the simple and commercially easy production of 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives. Moreover, the production method according to one embodiment of the present invention makes it possible to economically produce 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011] One embodiment of the present invention provides a method for synthesizing a 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivative represented by formula 4, comprising the steps of: (a) reducing a compound represented by formula 1 to produce a compound represented by formula 2; and (b) coupling the compound represented by formula 2 with a compound represented by formula 3: [ka] In the above chemical formula: The dotted lines are optional double bonds; R1 and R2 are each independently one of a hydrogen atom; a substituted or unsubstituted, linear or branched C1-C6 alkyl group; a halogen atom; a substituted or unsubstituted, linear or branched C1-C6 alkoxy group; a substituted or unsubstituted, linear or branched C1-C4 thioalkyl group; a substituted or unsubstituted allyloxy group; a substituted or unsubstituted aryloxy group; and a phenyl group; R3 is any one of a hydrogen atom; a C1-C3 alkyl group; a C1-C3 alkoxy group; and a halogen atom; R4 and R5 are each independently one of a hydrogen atom and a C1-C2 alkyl group; P is one of a substituted or unsubstituted, straight or branched C1-C4 alkyl group; a substituted or unsubstituted benzyl group; an allyl group; a t-butyldimethylsilyl group; a t-butyldiphenylsilyl group; a dimethylphenylsilyl group; a trimethylsilyl group; MeSO2; a p-toluenesulfonyl group; and a 2,4,6-trimethylbenzenesulfonyl group; n is 1 to 3; When there are multiple OPs, they may be the same or different; In the case of the substituted alkyl group, substituted alkoxy group, substituted thioalkyl group, substituted allyloxy group, substituted aryloxy group and substituted benzyl group, the substituent is any one of a benzyloxy group, a halogen atom, a linear or branched C1-C5 alkyl group, a linear or branched C1-C5 alkoxy group; a linear or branched C1-C3 thioalkyl group, a nitro group and a naphthalene group.

[0012] In the case of synthesizing the compound of formula A-4 (the compound of formula 4 of the present invention) as shown in Reaction Scheme A of Patent Document 2 [Korea Patent Publication No. 10-2018-0037584], not only must the reaction proceed at an extremely low temperature, but also must require expensive L-selectride. RHowever, when synthesizing the compound of formula 4 according to one embodiment of the present invention, the compound of formula 1 is first reduced, and then the compound of formula 2 thus produced is coupled with the compound of formula 3, eliminating the need to carry out the reduction reaction at a very low temperature and the need to use an expensive reducing agent. Therefore, the 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivative can be easily and commercially produced in a simple manner.

[0013] Examples of the 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivative represented by the above Chemical Formula 4 include the following compounds. [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]

[0014] Hereinafter, each step of the method for synthesizing the compound of Chemical Formula 4 according to one embodiment of the present invention will be described in more detail.

[0015] Step (a) according to one embodiment of the present invention is a step of producing a compound of chemical formula 2 by reducing the formyl group (-COH) of a compound of chemical formula 1. The reduction is carried out at 0°C to 5°C using a reducing agent such as sodium borohydride, lithium aluminum hydride, or diisobutyl aluminum hydride. Specifically, the reducing agent may be sodium borohydride or lithium aluminum hydride. As shown in the Background Art of the Invention, in Patent Document 2, the step of reducing a compound of chemical formula A-3 to a compound of chemical formula A-4 must selectively reduce only the formyl group without reducing the carbonyl group of the ketone, which is problematic in that a selective reducing agent must be used at extremely low temperatures. However, the synthesis method of the present invention reduces a compound of chemical formula 1 first, and can easily produce a compound of chemical formula 4 under mild conditions without using a selective reducing agent.

[0016] According to one embodiment of the present invention, the step (b) may be carried out under basic conditions. For example, the step (b) may be carried out using a basic compound.

[0017] According to one embodiment of the present invention, the basic conditions may be achieved by the addition of one or more basic compounds selected from sodium hydroxide (NaOH), potassium hydroxide (KOH), sodium carbonate (Na2CO3), lithium carbonate (Li2CO3), potassium carbonate (K2CO3), sodium bicarbonate (NaHCO3), potassium bicarbonate (KHCO3), triethylamine and pyridine, and more specifically, may be potassium carbonate or sodium carbonate.

[0018] Another embodiment of the present invention provides a method for synthesizing a 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative of formula I, comprising the steps of (i) cyclizing a compound of formula 4 prepared according to an embodiment of the present invention to produce a compound of formula 5, and (ii) reducing the compound of formula 5: [ka] In the above chemical formula, the dotted line is an optional double bond, and R1 to R5, P and n are the same as defined in the above chemical formulas 1 to 4.

[0019] When the compound of formula 4 is cyclized to the compound of formula 5, i) the compound of formula 4 is dissolved in acetonitrile, and triphenylphosphonium bromide (Ph3P·HBr) is added to obtain an intermediate, and ii) the intermediate of i) is concentrated, and then the concentrate is dissolved and sodium ethoxide (NaOEt) is added to perform cyclization.

[0020] The step (ii) may be a step of reducing the double bond in the compound of formula 5 and removing the protecting group to synthesize the compound of formula I. The removing of the protecting group is carried out by a hydrogenation reaction using Pd / C (palladium on carbon) as a catalyst, which is the same as the reaction for reducing the double bond.

[0021] Yet another embodiment of the present invention provides a 6-(hydroxymethyl)chromen-5-ol derivative or a solvate thereof represented by the following chemical formula 2: [ka] In the above Chemical Formula 2, R3 is any one of a hydrogen atom; a C1-C3 alkyl group; a C1-C3 alkoxy group; and a halogen atom; R4 and R5 are each independently one of a hydrogen atom; and a C1-C2 alkyl group.

[0022] Examples of the 6-(hydroxymethyl)chromen-5-ol derivative represented by Chemical Formula 2 include the following compounds. [ka] EXAMPLES

[0023] The present invention will be described in more detail with reference to one or more embodiments, however, the present invention is not limited to these embodiments.

[0024] Example 1: Preparation of 2-(6-hydroxymethyl)-2,2-dimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethanone (Compound 4-1) 1-1. Synthesis of 6-(hydroxymethyl)-2,2-dimethyl-2H-chromen-5-ol [ka] 3g (0.01469mol) of 5-hydroxy-2,2-dimethyl-2H-chromene-6-carbaldehyde was added to 60ml of methanol and cooled to 0-5℃, and then 0.28g (0.0074mol) of sodium borohydride was added in 4 portions. The reaction solution was warmed to room temperature and stirred for an additional 30 minutes. After the reaction was completed, the reaction solution was concentrated, and then 60ml of ethyl acetate and 15ml of purified water were added. While stirring vigorously, acetic acid was slowly added to adjust the pH to 6-6.5. After layer separation, the aqueous layer was removed, and the organic layer was washed with 15ml of brine and 2% aqueous sodium bicarbonate solution in sequence. The organic layer was treated with anhydrous water, filtered, concentrated, and then crystallized from n-hexane to obtain 2.37 g (yield 78.2%) of 6-(hydroxymethyl)-2,2-dimethyl-2H-chromen-5-ol. 1 H-NMR and 13 The results of C-NMR are as follows:

[0025] 1 H-NMR (CDCl3): 7.596(s, 1H), 6.715(d, 1H, J=10Hz), 6.686(d, 1H, J=10Hz), 6.287(d, 1H, 8.4H), 5.587(d, 1H, J=10Hz), 4.746(s, 2H), 2.296(br, 1H), 1.412(s, 6H). 13 C-NMR (CDCl3): 153.842, 152.180, 129.192, 127.311, 116.803, 116.548, 110.336, 107.820, 75.957, 64.751, 27.730.

[0026] 1-2. Synthesis of 2-(6-(hydroxymethyl)-2,2-dimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethanone [ka] 5g (0.0242mol) of 6-(hydroxymethyl)-2,2-dimethyl-2H-chromen-5-ol, 8.47g (0.0242mol) of 1-(2-(benzyloxy)-4-ethoxyphenyl)-2-bromoethanone, and 7.4g (0.0535mol) of potassium carbonate were added to 50ml of acetone and stirred at room temperature overnight. After the reaction was completed, the mixture was filtered and the filtrate was completely concentrated. Methylene chloride was added to the concentrated liquid and washed with purified water. The organic layer was treated to remove all traces of anhydrous matter, concentrated, and crystallized from n-hexane to obtain 10.8g (yield 93.9%) of 2-(6-(hydroxymethyl)-2,2-dimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethanone. The results of the analysis of the compound obtained were as follows: 1 H-NMR and 13 The results of C-NMR are as follows:

[0027] 1 H-NMR (CDCl3): 8.063(d, 1H, J=8.8Hz), 7.35~7.32(m, 5H), 7.001(d, 1H, J=8.4Hz), 6.585(dd, 1H, J=8.8, 2.0Hz), 6.532(d, 1H, J=8.0Hz), 6.503(d, 1H, J=2.0Hz), 6.383(d, 1H, J=10Hz), 5.464(d, 1H, J=9.6Hz), 5.092(s, 2H), 5.065(s, 2H), 4.522(s, 2H), 4.078(q, 2H, J=13.6), 3.502(br, 1H), 1.424(t, 3H, J=6.8Hz), 1.367(s, 6H). 13 C-NMR (CDCl3): 194.136, 164.785, 160.506, 154.276, 153.734, 135.384, 133.298, 130.280, 129.713, 128.772, 128.570, 127.905, 126.120, 117.735, 117.273, 114.343, 112.067, 106.684, 99.536, 80.734, 75.497, 70.927, 63.988, 61.479, 27.543, 14.594.

[0028] Example 2. Preparation of 2-(6-(hydroxymethyl)-2,2,7-trimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethanone (Compound 4-2) 2-1. Synthesis of 6-(hydroxymethyl)-2,2,7-trimethyl-2H-chromen-5-ol [ka] 6-(hydroxymethyl)-2,2,7-trimethyl-2H-chromen-5-ol was obtained by the same method as in Example 1-1, except that 5-hydroxy-2,2-dimethyl-2H-chromen-6-carbaldehyde was used instead of 5-hydroxy-2,2,7-trimethyl-2H-chromen-6-carbaldehyde. 1 H-NMR and 13 The results of C-NMR are as follows:

[0029] 1H-NMR (CDCl3): 8.066(s, 1H), 6.648(d, 1H, J=10Hz), 6.167(s, 1H), 5.525(d, 1H, J=10Hz), 4.827(s, 2H), 2.401(br, 1H), 2.132(s, 3H), 1.399(s, 6H). 13 C-NMR (CDCl3): 152.863, 152.580, 135.759, 128.156, 116.639, 114.949, 109.944, 108.437, 75.880, 60.798, 27.735, 19.462.

[0030] 2-2. Synthesis of 2-(6-(hydroxymethyl)-2,2,7-trimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethanone [ka] Except for using 6-(hydroxymethyl)-2,2,7-trimethyl-2H-chromen-5-ol instead of 6-(hydroxymethyl)-2,2-dimethyl-2H-chromen-5-ol, the same method as in Example 1-2 was carried out to obtain 2-(6-(hydroxymethyl)-2,2,7-trimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethanone. 1 H-NMR and 13 The results of C-NMR are as follows:

[0031] 1H-NMR (CDCl3): 8.047(d, 1H, J=8.8Hz), 7.375~7.279(m, 5H), 6.574(dd, 1H, J=9.2, 2.4Hz), 6.495(d, 1H, J=2.4Hz), 6.479(s, 1H), 6.330(d, 1H, J=10Hz), 5.405(d, 1H, J=9.6Hz), 5.120(s, 2H), 5.078(s, 2H), 4.618(d, 2H, J=6.4Hz), 4.126~4.044(m, 2H), 3.156(br, 1H), 2.325(s, 3H), 1.417(t, 3H, J=7.2Hz), 1.359(s, 6H). 13 C-NMR (CDCl3): 192.848, 164.723, 160.478, 154.581, 153.075, 139.010, 135.408, 133.229, 130.478, 129.135, 128.710, 128.665, 128.507, 127.920, 124.442, 117.383, 114.026, 111.674, 81.044, 75.421, 63.952, 56.773, 27.547, 19.331, 14.574.

[0032] Example 3. Preparation of 2-(6-(hydroxymethyl)-7-methoxy-2,2-dimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethanone (Compound 4-3) 3-1. Synthesis of 6-(hydroxymethyl)-7-methoxy-2,2-dimethyl-2H-chromen-5-ol [ka] 6-(hydroxymethyl)-7-methoxy-2,2-dimethyl-2H-chromen-5-ol is obtained by carrying out the same method as in Example 1-1, except that 5-hydroxy-7-methoxy-2,2-dimethyl-2H-chromen-6-carbaldehyde is used instead of 5-hydroxy-2,2-dimethyl-2H-chromen-6-carbaldehyde. 1 H-NMR and 13 The results of C-NMR are as follows:

[0033] 1 H-NMR (CD3OD): 6.741(d, 1H, J=9.6Hz), 5.819(s, 1H), 5.350(d, 1H, J=9.6Hz), 4.627(s, 2H), 3.724(s, 3H), 1.369(s, 6H). 13 C-NMR (CD3OD): 157.480, 154.814, 153.923, 124.960, 119.470, 107.049, 105.714, 90.203, 76.517, 58.645, 55.602, 27.885.

[0034] 3-2. Synthesis of 2-(6-(hydroxymethyl)-7-methoxy-2,2-dimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethenone [ka] Except for using 6-(hydroxymethyl)-7-methoxy-2,2-dimethyl-2H-chromen-5-ol instead of 6-(hydroxymethyl)-2,2-dimethyl-2H-chromen-5-ol, the same method as in Example 1-2 is carried out to obtain 2-(6-(hydroxymethyl)-7-methoxy-2,2-dimethyl-2H-chromen-5-yloxy)-1-(2-(benzyloxy)-4-ethoxyphenyl)ethanone. 1 H-NMR and 13 The results of C-NMR are as follows:

[0035] 1 H-NMR (CDCl3): 8.048(d, 1H, J=8.8Hz), 7.386~7.296(m, 5H), 6.567(dd, 1H, J=8.8, 2Hz), 6.509(s, 1H), 6.369(d, 1H, J=10Hz), 6.207(s, 1H), 5.348(d, 1H, J=10Hz), 5.120(s, 2H), 5.088(s, 2H), 4.637(d, 2H, J=6.8Hz), 4.060(q, 2H, J=14, 7.2Hz), 3.799(s, 3H), 3.032(t, 1H, J=6.4Hz), 1.411(t, 3H, J=6.8Hz), 1.366(s, 6H). 13 C-NMR (CDCl3): 193.599, 164.605, 160.395, 158.879, 154.891, 154.317, 135.459, 133.157, 128.641, 128.364, 127.786, 127.088, 117.880, 117.249, 114.782, 107.335, 106.616, 99.520, 95.947, 81.138, 76.028, 70.810, 63.914, 55.636, 54.542, 27.569, 14.561.

[0036] Thereafter, using the same method as in Example 1, various 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives as shown in Table 1 below were synthesized.

[0037] [Table 1-1] [Table 1-2] [Table 1-3] [Table 1-4] [Table 1-5] [Table 1-6] [Table 1-7] [Table 1-8] [Table 1-9] [Table 1-10] [Table 1-11] [Table 1-12] [Table 1-13] [Table 1-14] [Table 1-15]

Table 1-16

Table 1-17

Table 1-18

Table 1-19

Table 1-20

Table 1-21

Table 1-22

Table 1-23

Table 1-24

Table 1-25

Table 1-26

Table 1-27

Table 1-28

Table 1-29

Table 1-30

Table 1-31

Table 1-32

[0038] Using the methods disclosed in the above examples, 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivatives can be prepared simply under mild conditions in a commercially easy and economical manner.

[0039] The present invention has been described above with a focus on its preferred embodiments. Those skilled in the art will understand that the present invention can be realized in modified forms without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is defined in the claims, not in the above description, and all differences within the scope of the claims should be interpreted as being included in the present invention.

Claims

1. (a) reducing a compound of formula 1 to produce a compound of formula 2; (b) coupling the compound of formula 2 with a compound of formula 3, to obtain a 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivative represented by formula 4: 【Chemistry 1】 In the above chemical formula: The dotted lines are optional double bonds; R 1 and R 2 are each independently a hydrogen atom; a substituted or unsubstituted, linear or branched chain C 1 -C 6 Alkyl group; halogen atom; substituted or unsubstituted, straight or branched chain C 1 -C 6 Alkoxy group; substituted or unsubstituted, straight or branched chain C 1 -C 4 a thioalkyl group; a substituted or unsubstituted allyloxy group; a substituted or unsubstituted aryloxy group; and a phenyl group; R 3 is a hydrogen atom; C 1 -C 3 Alkyl group; C 1 -C 3 an alkoxy group; and a halogen atom; R 4 and R 5 are each independently a hydrogen atom; and C 1 -C 2 any one of the alkyl groups; P is a substituted or unsubstituted, linear or branched chain C 1 -C 4 Alkyl group; substituted or unsubstituted benzyl group; allyl group; t-butyldimethylsilyl group; t-butyldiphenylsilyl group; dimethylphenylsilyl group; trimethylsilyl group; MeSO 2 p-toluenesulfonyl group; and 2,4,6-trimethylbenzenesulfonyl group; n is 1 to 3; When there are multiple OP's, they may be the same or different; In the case of the substituted alkyl group, substituted alkoxy group, substituted thioalkyl group, substituted allyloxy group, substituted aryloxy group and substituted benzyl group, the substituent is a benzyloxy group, a halogen atom, a straight-chain or branched C 1 -C 5 Alkyl group, straight or branched chain C 1 -C 5 Alkoxy group, linear or branched C 1 -C 3 It is any one of a thioalkyl group, a nitro group, and a naphthalene group.

2. The method for synthesizing a 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivative according to claim 1, wherein the step (b) is carried out under basic conditions.

3. The basic conditions include sodium hydroxide (NaOH), potassium hydroxide (KOH), sodium carbonate (Na 2 CO 3 ), lithium carbonate (Li 2 CO 3 ), potassium carbonate (K 2 CO 3 ), sodium bicarbonate (NaHCO 3 ), potassium bicarbonate (KHCO 3 3. The method for synthesizing the 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivative according to claim 2, wherein the method is carried out by adding one or more basic compounds selected from the group consisting of triethylamine and pyridine.

4. (i) preparing a compound of formula 4 according to the synthesis method of any one of claims 1 to 3, and cyclizing the compound of formula 4 to prepare a compound of formula 5; (ii) reducing the compound of formula 5, 【Chemistry 2】 In the above chemical formula: The dotted lines are optional double bonds; R 1 and R 2 are each independently a hydrogen atom; a substituted or unsubstituted, linear or branched chain C 1 -C 6 Alkyl group; halogen atom; substituted or unsubstituted, straight or branched chain C 1 -C 6 Alkoxy group; substituted or unsubstituted, straight or branched chain C 1 -C 4 a thioalkyl group; a substituted or unsubstituted allyloxy group; a substituted or unsubstituted aryloxy group; and a phenyl group; R 3 is a hydrogen atom; C 1 -C 3 Alkyl group; C 1 -C 3 an alkoxy group; and a halogen atom; R 4 and R 5 are each independently a hydrogen atom; and C 1 -C 2 any one of the alkyl groups; P is a substituted or unsubstituted, linear or branched chain C 1 -C 4 Alkyl group; substituted or unsubstituted benzyl group; allyl group; t-butyldimethylsilyl group; t-butyldiphenylsilyl group; dimethylphenylsilyl group; trimethylsilyl group; MeSO 2 p-toluenesulfonyl group; and 2,4,6-trimethylbenzenesulfonyl group; n is 1 to 3; When there are multiple OP's, they may be the same or different; In the case of the substituted alkyl group, substituted alkoxy group, substituted thioalkyl group, substituted allyloxy group, substituted aryloxy group and substituted benzyl group, the substituent is a benzyloxy group, a halogen atom, a straight-chain or branched C 1 -C 5 Alkyl group, straight or branched chain C 1 -C 5 Alkoxy groups, and straight or branched chain C 1 -C 3 It is any one of a thioalkyl group, a nitro group, and a naphthalene group.

5. Use of a 6-(hydroxymethyl)chromen-5-ol derivative represented by the following chemical formula 2 or a solvate thereof for synthesizing a compound represented by the chemical formula 4 according to the synthesis method of claim 1: 【Chemistry 3】 In the above Chemical Formula 2, R 3 is a hydrogen atom; C 1 -C 3 Alkyl group; C 1 -C 3 an alkoxy group; and a halogen atom; R 4 and R 5 are each independently a hydrogen atom; and C 1 -C 2 The alkyl group is any one of the alkyl groups.

Citation Information

Patent Citations

  • Method for synthesizing glabridin

    CN103030647A

  • Benzopyrans compound as well as preparation method and application thereof

    CN108822065A

  • Method for producing isoflavan derivative

    JP2006008604A

  • Pyranochromenylphenol derivatives and a pharmaceutical composition for treating metabolic syndrome or inflammatory disease

    KR1020150075030A

  • METHOD FOR SYNTHESIZING 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-f]CHROMENE DERIVATIVE AND OPTICAL ISOMER OF THEREOF

    KR1020180037584A